Kishta Katipally
Associate Director, CMC Drug Substance Operations at TG Therapeutics, Inc. - New York, NY, US
Kishta Katipally's Colleagues at TG Therapeutics, Inc.
Kishta Katipally's Contact Details
HQ
(212) 554-4484
(212) 554-4484
Location
New York City Metropolitan Area
New York City Metropolitan Area
Company
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Kishta Katipally's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Frequently Asked Questions about Kishta Katipally
Kishta Katipally currently works for TG Therapeutics, Inc..
Kishta Katipally's role at TG Therapeutics, Inc. is Associate Director, CMC Drug Substance Operations.
Kishta Katipally's email address is ***@tgtxinc.com. To view Kishta Katipally's full email address, please signup to ConnectPlex.
Kishta Katipally works in the BioTech/Drugs industry.
Kishta Katipally's colleagues at TG Therapeutics, Inc. are Fred Chan, Sydney Roth, Alexis Kudyba, Sally Styring, Brett Smith, Benjamin Yee, Gregory Yen and others.
Kishta Katipally's phone number is (212) 554-4484